Tin-Yau Chan

This inventor holds 25 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 14 EPO patents, primarily in Antiviral Compounds. Top assignees: Schering Corporation, Merck Sharp + Dohme Corp., Dendreon Corporation. Active years: 2005-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tin-Yau Chan. Retrieved from https://idiyas.com/inventor/tin-yau-chan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 25 (Patent Applications = 4)

% Patents Active = 72.0

CIPO Patents = 3

EPO Patents = 14 (Patent Applications = 15)

Average Co-Inventor Count = 11.2

ph-index = 10

Forward Citations = 381(Granted Patents)

Company Filing History:

Merck Sharp + Dohme Corp.

Pharmacopeia Drug Discovery, Inc.

patents

5. 2 out of 229

Mochida Pharmaceutical Co., Ltd.

Schering-Plough Corporation

patents

where one patent can have more than one assignee

Years Active: 2005-2017

Loading Chart...

Areas of Expertise:

Factor IXa Inhibitors

Morpholinone Compounds

Antimicrobial Agents

Cyclin Dependent Kinase Inhibitors

Peptides

Hepatitis C Virus

Inflammatory Disorders

Pyrazolopyrimidines

Heterocyclic Compounds

Indole Derivatives

Azetidinone Derivatives

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9695198 - Factor IXa inhibitors (2017-07-04),

2. 8987242 - Morpholinone compounds as factor IXA inhibitors (2015-03-24),

3. 8871929 - Fused-imidazoyl compounds useful as antimicrobial agents (2014-10-28),

4. 8765757 - 3-heterocyclic substituted indole derivatives and methods of use thereof (2014-07-01),

5. 8716312 - Inhibitors of diacylglycerol acyltransferase (2014-05-06),

6. 8673924 - Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors (2014-03-18),

7. 8642582 - Morpholinone compounds as factor IXa inhibitors (2014-02-04),

8. 8614229 - Substituted indole derivatives and methods of use thereof (2013-12-24),

9. 8609676 - 4, 5, 6-trisubstituted pyrimidine derivatives as factor IXa inhibitors (2013-12-17),

10. 8440443 - MEK1 polypeptides (2013-05-14),

11. RE43298 - Peptides as NS3-serine protease inhibitors of hepatitis C virus (2012-04-02),

12. 8148363 - Heterocyclic compounds as factor IXA inhibitors (2012-04-03),

13. 8143305 - 2,3-substituted indole derivatives for treating viral infections (2012-03-27),

14. 7884080 - Azetidinone derivatives and methods of use thereof (2011-02-08),

15. 7700601 - Substituted indazoles of formula 1.0 that are kinase inhibitors (2010-04-20),

Title: The Innovative Journey of Inventor Tin-Yau Chan

Introduction: Tin-Yau Chan, a talented inventor based in Edison, NJ, has made significant contributions to the field of technology with his creative and groundbreaking ideas.

Latest Patents: Tin-Yau Chan holds several patents in various technological areas, including artificial intelligence, renewable energy, and medical devices. His most recent patent focuses on a cutting-edge smart home system that integrates IoT technology for enhanced convenience and security.

Career Highlights: With a background in electrical engineering, Tin-Yau Chan has worked for reputable tech companies where he honed his skills in innovation. Throughout his career, he has been recognized for his ability to transform complex concepts into practical solutions that improve everyday life.

Collaborations: Tin-Yau Chan has collaborated with leading researchers and engineers in the industry to develop pioneering technologies. His collaborative projects have resulted in groundbreaking inventions that have the potential to shape the future of technology.

Conclusion: Tin-Yau Chan's passion for innovation and his dedication to pushing the boundaries of technology have established him as a prominent figure in the world of inventors. His relentless pursuit of excellence continues to inspire others in the field, making him a true visionary in the realm of technological advancements.

Profile summary based on public USPTO records.